Document Title: Fabtech Technologies Board Meeting Outcome - Management Appointments and Retirements

Summary of Key Information:

Reporting Period (Quarter/Year): Not Specified

Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 of SEBI Listing Regulations

Date of Board Meeting / Approval: May 25, 2026 (Meeting time: 3:30 pm to 4:00 pm)

Audit Opinion: Not Specified

Auditor's Comment: Not Specified

Key Financial Highlights: Not Specified

Standalone Results: Not Specified

Consolidated Results: Not Specified

Segment-wise Performance: Not Specified

Corporate Actions:

  • No dividend declarations, share splits, bonus issues, buybacks, or capital structure changes announced
  • No capital raising activities mentioned

Regulatory Disclosures:

  • Appointment of Ms. Bharti Khanna (DIN: 05147844) as Additional Director (Non-Executive & Independent) effective immediately for five consecutive years, subject to shareholder approval
  • Draft Postal Ballot Notice approved for seeking shareholder approval for:
  • Appointment of Ms. Rupal Dhiren Haria (DIN: 10624643) as Non-Executive Independent Director
  • Appointment of Ms. Bharti Khanna (DIN: 05147844) as Non-Executive Independent Director
  • Appointment of Mr. Ajaj Abdul Rahiman Kazi as Senior Vice President and Senior Management Personnel effective May 25, 2026
  • Retirement of Senior Management Personnel:
  • Mr. Dilip Ghosh, Senior Vice-President Operations, effective closure of business hours May 25, 2026
  • Mr. Ranganathan Gkseetharaman, Assistant Vice President Logistics, effective closure of business hours May 25, 2026

Director Profiles:

  • Ms. Bharti Khanna: Holds bachelor's and master's degree in pharmaceutics from DPSRU, University of Delhi, with specialization in marketing management. 30+ years experience in pharmaceutical industry with expertise in R&D, scale-up, technology transfer, global regulatory affairs, pharmacovigilance, GMP compliance, and strategic project management. Member of Institutional Quality Assurance Cell at Delhi Pharmaceutical Sciences and Research University, Council Member of Society of Pharmaceutical Education & Research (Women Forum) and Women's Indian Chamber of Commerce and Industry, lifetime member of Indian Pharmaceutical Association (IPA) and Indian Pharmacy Graduates' Association (IPGA). Founder of Pharma Learning Portal. No relationship with any current board members. Not debarred from holding director office.
  • Mr. Ajaj Abdul Rahiman Kazi: Seasoned professional with 27+ years experience in MEP project management, business development, operations and P&L management. Previously Head – MEP at Reliance Industries and held leadership positions with Voltas Limited for 23+ years. Expertise in project execution, stakeholder management, contract management and team leadership. Certified Project Management Professional (PMP). Held key leadership roles in ISHRAE and ASHRAE.

Other Significant Information:

  • The requisite disclosures as required under Regulation 30 of SEBI Listing Regulations are enclosed as Annexure A, B, and C
  • Notice of Postal Ballot including related information will be published and communicated in due course as per Companies Act, 2013 and SEBI Listing Regulations
  • Since the SMP changes are due to retirement, requirement of Resignation Letter is not applicable